Category Archives: Innovation

Creativity according to Isaac Asimov

While travelling in the USA in January, I was mentioned a 1959 Essay by Isaac Asimov on Creativity “How Do People Get New Ideas?”.


Isaac Asimov by Andy Friedman (Source: MIT Technology Review)

I have always been skeptical about how to teach creativity or even how to encourage it. I felt very much in agreement with what Asimov had written way back 60 years ago. Let me quote him:

– the method of generation [of ideas] is never clear even to the “generators” themselves,

– what is needed is not only people with a good background in a particular field, but also people capable of making a connection between item 1 and item 2 which might not ordinarily seem connected,

– once the cross-connection is made, it becomes obvious,

– making the cross-connection requires a certain daring,

– a person willing to fly in the face of reason, authority, and common sense must be a person of considerable self-assurance; since (s)he occurs only rarely, (s)he must seem eccentric (in at least that respect) to the rest of us,

– my feeling is that as far as creativity is concerned, isolation is required; the creative person is, in any case, continually working at it; his (her) mind is shuffling information at all times, even when (s)he is not conscious of it,

– the presence of others can only inhibit this process, since creation is embarrassing; nevertheless, a meeting of such people may be desirable for reasons other than the act of creation itself,

– the optimum number of the group [i.e. such people just before] would probably not be very high. I should guess that no more than five would be wanted.

This is quite fascinating: according to Asimov, creativity is an isolated act; making connections possible maybe helped by small groups, but even this, Asimov is not totally convinced of… I have often read interesting articles about creativity in art, science, technology and the idea that freedom to think combined with obsession to solve or do something might be much more critical than social interactions.

A New Yorker article about 2 Google developers : The Friendship That Made Google Huge

The New Yorker just published a beautiful article abotu two google developers. The Friendship That Made Google Huge is subtitled Coding together at the same computer, Jeff Dean and Sanjay Ghemawat changed the course of the company—and the Internet.


The company’s top coders seem like two halves of a single mind.
Illustration by David Plunkert

Here are some extracts:

Sanjay Ghemawat, [is] a quiet thirty-three-year-old M.I.T. graduate with thick eyebrows and black hair graying at the temples. Sanjay had joined the company only a few months earlier, in December. He’d followed a colleague of his—a rangy, energetic thirty-one-year-old named Jeff Dean—from Digital Equipment Corporation. Jeff had left D.E.C. ten months before Sanjay. They were unusually close, and preferred to write code jointly. In the war room, Jeff rolled his chair over to Sanjay’s desk, leaving his own empty. Sanjay worked the keyboard while Jeff reclined beside him, correcting and cajoling like a producer in a news anchor’s ear.

[…]

Today, Google’s engineers exist in a Great Chain of Being that begins at Level 1. At the bottom are the I.T. support staff. Level 2s are fresh out of college; Level 3s often have master’s degrees. Getting to Level 4 takes several years, or a Ph.D. Most progression stops at Level 5. Level 6 engineers—the top ten per cent—are so capable that they could be said to be the reason a project succeeds; Level 7s are Level 6s with a long track record. Principal Engineers, the Level 8s, are associated with a major product or piece of infrastructure. Distinguished Engineers, the Level 9s, are spoken of with reverence. To become a Google Fellow, a Level 10, is to win an honor that will follow you for life. Google Fellows are usually the world’s leading experts in their fields. Jeff and Sanjay are Google Senior Fellows—the company’s first and only Level 11s.

And more about dual creativity. Quite fascinating!

It took Monet and Renoir, working side by side in the summer of 1869, to develop the style that became Impressionism; during the six-year collaboration that gave rise to Cubism, Pablo Picasso and Georges Braque would often sign only the backs of their canvases, to obscure which of them had completed each painting.
[…]
In “Powers of Two: Finding the Essence of Innovation in Creative Pairs,” the writer Joshua Wolf Shenk quotes from a 1971 interview in which John Lennon explained that either he or Paul McCartney would “write the good bit, the part that was easy, like ‘I read the news today’ or whatever it was.” One of them would get stuck until the other arrived—then, Lennon said, “I would sing half, and he would be inspired to write the next bit and vice versa.”
[…]
François Jacob, who, with Jacques Monod, pioneered the study of gene regulation, noted that by the mid-twentieth century most research in the growing field of molecular biology was the result of twosomes.

You should read the article…

What Is Innovation?

So what is innovation? I had already addressed the question in 2015 in Invention, Entrepreneurship and Innovation. My colleague Federico gave me a few days ago another definition of Innovation from MIT’s Bill Aulet.

Innovation = Invention ∗ Commercialization

You will find the video here.

And here some extracts:

So could it have been “Innovation equals invention?” No, often people mistake these two things for the same thing. They are not. Innovation is something that generates value for the world. It makes something faster, better, cheaper. It gives someone some great satisfaction. An invention is an idea, a technology, a patent. In and of itself, it does not generate value. So these two are not the same thing. And sometimes you see them interchange. And that’s not correct.

So innovation equals invention times commercialization. And when we look at this equation of innovation, something of value, it requires a new idea. And then, it requires someone or some organization that is going to commercialize that idea and to make it a value to the world. So it’s important to understand that an idea by itself is not valuable. Ideas are cheap. Is the commercialization when combined with it that makes them extraordinarily valuable. So while sometimes when I used to say invention plus commercialization, in fact, it’s times.

It’s a product because if I don’t have one, then it’s zero. Then, I have no innovation. If I have no new idea, I can’t commercialize anything. Therefore, it’s zero. If I have an invention and no commercialization, I have no innovation as well. So it’s actually a product. It’s, in fact, the commercialization aspect of it that’s very, very difficult.

If you look at the most innovative company in the world today, which I would argue is Apple, the underlying inventions that created Apple, great innovations starting with the Mac, did not come from themselves. It actually came from Xerox PARC. It was windows, icon, mouse, pointer. That invention, they commercialized to create innovation, which created terrific value in the marketplace and for their customers and for themselves, their investors as well. Likewise after that, you look again that the invention for the underlying and enabling idea, technology from the iPod was MP3, which did not come from Apple, again. That came from Fraunhofer. But what Apple was terrific at was commercialization to create innovation and, again, to create great value for their customers and their shareholders. So this definition of innovation we found very, very helpful to make clear that innovation is a combination of a new idea, a new technology. But then, it has to be commercialized and mapped to some customer in the real world where it will generate value.

Thanks Federico 🙂

XXIst Century Utopias according to Libero Zuppiroli

In his latest book, Les utopies du XXIe siècle (The Utopias of the 21st Century) Libero Zuppiroli makes an original presentation of what I call the excessive promises of innovation. I wrote recently a short chronicle about it in Enterprise Romande and Bernard Stiegler makes a much more pessimistic analysis in In the disruption – How not to go crazy? A third very interesting reference is the collective work Emerging Science and Technologies, why so many promises?

Libero Zuppiroli tackles the issue from the perspective of utopias and dystopias, using in the beginning of his book ancient authors of the eighteenth and nineteenth centuries, that show that excessive optimism has always existed and that its realistic, even pessimistic, counterpart has also always accompanied it. Flora Tristan in 1840 mirrors Sadi Carnot’s benefits of the machine in 1824, Marat in 1774 is paralleled to Adam Smith’s economic liberalism in 1776, and Francis Bacon, in 1627, dreamed of never ending scientific and technological progress. The utopian promises are not new!

It is a book that must be read and I will let you discover the analyses of the promises in the fields of information technology, robotics, defense, 3D printers and nanotechnologies, the city and energy, health, and big data. A simple illustration: around 2005, nanotechnologies were seen as an extremely promising market, which would reach 3’000 billion dollars in 10 years. More than 10 years later, the market is around $100 millions…

I fear, however, that Libero Zuppiroli does not have much illusions about the impact of his analyzes. In a note on critical authors (note 119, page 293), he writes, “He is one of these famous intellectual critics whom American society not only tolerates, but also encouraged the birth of. Their critic of the American system is harsh and based on remarkable analyzes, but those who possess the power know that, despite their international reputation, the audience of these intellectuals is limited to a small fraction of people already convinced. Whatever their talent, their influence on the masses of electors will always be much lower than that of teleevangelists.”

But I knew Libero Zuppiroli was playful and his conclusion confirms this to me: this Empire will collapse as previously collapsed the Roman, Napoleonic and Soviet Empires. When? Nobody knows … but it will collapse victim of its Hubris

PS (October 29, 2018): the reader may also be interested in another blog contribution: Dissecting the utopias of the 21st century by Diane Golay.

Virtual Innovations?

I had not contributed to Entreprise Romande for a while, which might be the reason of my somehow tiredness about the never ending flow of (virtual?) innovations. Here is my translation of my latest contribution…

When the editor of your favorite magazine asked me for a new contribution about innovation, offering me to write about bitcoin, artificial intelligence, data protection, GAFAs or China, I was the victim if not of a slight dizziness, at least of a certain weariness. I just had to add to this list Fake news, Trips to Mars or Replacement of Humans by Machines and my ongoing passion for startups and technological innovation turned into a light nightmare. It seems to me that the more we talk about innovation and the less we really innovate.

When I explain my slight skepticism to anybody, they usually start with the mention of replacing the cashier of the Migros (a “famous” chain of Swiss supermarkets) with a machine. I reply that it seems to me that we, buyers, have replaced the cashier. If the media relayed in 2011 Foxconn’s announcement that it wanted to install a million robots in 3 years, threatening the 1.2 million employees, an online search indicates today that it has a ability to install 10,000 robots a year, and still the same number of employees.

Silicon Valley, having been at the origin of the major innovations of the last fifty years, is scrutinized more attentively. Of course the GAFAs represent a real threat: the two A become the supermarket of the world while the G and F support them by advertisements based on data that we have kindly given them, putting them in a quasi-monopoly situation. But you read well, supermarket, advertising. And that is what is called major innovations?

And what about globalized venture capital? Softbank has announced the launch of a 100 billion fund, by far the largest ever. In the last two months, 10 internet startups (including Dropbox and Spotify) have announced their intention to go public. The figures are dizzying: they generated 10 billion in revenues and 2 billion losses in 2017, thanks to 4 billion of funds raised since their creation. Venture capital has become an infernal machine that, like China and the GAFAs, seems unstoppable. But the venture capital that financed in 1976 Genentech and Apple with a few millions today massively funds the “uberisation” of the world, new global supermarket, and less and less the “deeptech”. I see in these trends an accelerated globalization but few major innovations.

When I think of the innovations of tomorrow, I think of nuclear fusion that will solve our energy problems, research on AIDS or cancer that will rid us of these disasters as we have been able to get rid of previous diseases, I think of disruptive solutions for water, food, mobility. Tom Perkins, Silicon Valley’s big venture capitalist, thought that the innovations of our time were based on three major inventions, the steam engine, the electricity and especially the transistor that made possible all the technologies that seem to threaten us today. But where is the next invention? I recognize myself in Peter Thiel’s phrase: “We wanted flying cars; instead, we had 140 characters. ”

Do not get me wrong, the innovation flow was exceptional in the 20th century and developments continue. In biotechnology, the Crispr-CAS9 technology [1] is as promising as the genetic revolution of the 1970s. Three startups, Crispr Therapeutics, Intellia Therapeutics and Editas Medicine went public in 2016 and promise to cure 10,000 diseases. But today these three companies represent less than $70 million in revenue and more than 200 million in losses in 2017. We do not yet have gene therapy or personalized medicine. Google’s Alphago beat the best go player, but nasty voices ​​say that it’s only the largest computing power and the largest data storage of computers that has allowed such performance, and no particular invention or intelligence . In more complex contexts, the machine is not able to compete with humans. And what will really bring us the multiplication of Big Data? But the promises of some to politicians and others to their shareholders, amplified by the media, are sometimes an insult to intelligence: why parasitize the human spirit with promises of (virtual) innovations sometimes more “abracadabrantesque” one than the others and ultimately disappointing when the real world is sufficiently complex and exciting?

[1] https://www.investors.com/news/technology/crispr-gene-editing-biotech-companies/

March 8 – International Women’s Day

About to give my optimization class this morning, I just remembered only one woman got the Fields Medal. This was in 2014. Unfortunately she died of cancer last year

Maryam Mirzakhani (3 May 1977 – 14 July 2017) became the first Iranian and first and only woman to win the Fields Medal.

Let me add, that in the field of optimization, apparently only one woman got the Dantzig Prize, Eva Tardos.

I have to admit, I did not take the time to think of a similar name for startups and innovation. Comments welcome…

Google is not Stanford largest license revenue anymore

Until early this morning, I thought that the Google license (i.e. the rights Stanford University had granted the startup on the PageRank patent) was the largest generator of licensing revenue for the Californian university. I was wrong! If you read the annual reports of OTL, its Office of Technology Licensing, for example the pdf of the 2016 Annual Report, you may notice that the largest royalty revenue generator had another source: intellectual property/patents about functional monoclonal antibodies. Here are what these reports say of the largest amount of revenue in a given year from a single invention:
2016: $64M
2015: $62.77M
2014: $60.53M
2013: $55M
2012: $51M
2011: $44M
2010: $45M
2009: $38M
2008: $37M
2007: $33.5M
2006: $29M
These numbers give a total of $363M and another book mentions $125M cumulatively before 2006. But a more recent powerpoint document shows that the total cumulative revenue is … $613M!!

As a side note, in 2005, the Google patent gave proceeds of $336M following the company IPO. The 2004 and 2003 reports do not say the amount of the largest source of income whereas in 2002, it was “an unexpected $5.8M in one-time royalties” and in 2001, “for the first time in over 20 years, a physical science invention – an optical fiber amplifier – generated the most income”.

As Lita Nelsen from MIT said (see my previous post), “Even nationwide, you can show that tech transfer is, at best, a lottery if you want to make an ability to influence [a university’s financial position]. The primary winners—not 100 percent of them, but damn close—are single pharmaceuticals. Because if a pharmaceutical hits the market, it’s going to be in the multi-billon dollar [range]. The equity is seldom worth a lot, unless of course you can follow up with preferred investments. But that’s not what we’re in the business of doing. Any university that counts on its tech transfer to make a significant change in its finances is statistically going to be in trouble.” Google was a big exception with the equity proceeeds whereas the patent around monoclonal antibodies or the Cohen Boyer patent are about pharma. Have a look at the next figure from the same powerpoint document.

Interestingly enough I am reading a very interesting book (more when I am finished) which describes the early days of Silicon Valley and in particular the creation of the office of Technology Licensing by Niels Rimers.

In Troublemakers, author Leslie Berlin extensively describes the Cohen Boyer patent. In note 32 (page 450), she describes the terms of the Cohen-Boyer license. You can also find them in Lessons from the Commercialization of the Cohen-Boyer Patents: The Stanford University Licensing Program.

73 companies has signed for the initial $10k upfront payment, but “ten companies alone provided 77% (US$197 million) of the total licensing income” and 3 (Amgen, Genentech and Lily) provided close to 50% of the total. All this is well-known but I thought it would be interesting to blog about it today.

MIT’s Lita Nelsen Perspective on Academic Technology Transfer

I just read an excellent interview of Lita Nelsen who has recently retired as head of MIT’s Technology Licensing Office. You should read the full Exit Interview: Lita Nelsen on MIT Tech Transfer, Startups & Culture. I was used to say that MIT was more conservative than Stanford just like the Boston Area has been known to be more conservtaive than California, but things change. So let me just mention a few extracts.


Lita Nelsen (Formerly head of MIT Technology Licensing Office)

About patents:

Patents are needed because the whole idea is if you’re going to get somebody to invest a lot of time and a lot of money, if you succeed you don’t want the other guy, the bigger guy, saying, “Well, thank you very much. Now that you’ve shown the way, get out of the way.” We are primarily using patents as an incentive for investment.

About universities having an investment fund:

[The Technology Licensing Office helps] start about 25 or 30 companies a year. God knows how many [other companies started on campus] go out the back door. No one fund could put that amount of sweat equity into all of them. Now imagine we have MIT’s fund, and I invest in company A, but don’t have the resources to do B, or maybe not C. Then I go with C to [an outside venture capital firm] and say, “How would you like my leftovers?” There’s a negative selection bias there for what we don’t invest in. So, better to let a level playing field for anybody who wants to play.

But one thing any institution doing it has to decide is, are we primarily in it for return on investment? Or are we primarily in it for getting companies started that wouldn’t otherwise get started? You usually get a mixed message if you ask people which it is. And as everybody knows, when you get mixed missions, things get very hard to manage.

About equity in licensing:

How much equity does the Technology Licensing Office usually take when it spins out a company? Usually in the lower single digits, maybe a little higher if you have a software spinout. And it’s common shares.

If it’s research-intensive stuff—biotech, things that take multiple rounds of funding—[our stake] usually gets demoted down to [tiny] portions. You make a little money; you don’t make a lot. Except in cases when the Wall Street bubble is totally irrational. Even nationwide, you can show that tech transfer is, at best, a lottery if you want to make an ability to influence [a university’s financial position]. The primary winners—not 100 percent of them, but damn close—are single pharmaceuticals. Because if a pharmaceutical hits the market, it’s going to be in the multi-billon dollar [range]. The equity is seldom worth a lot, unless of course you can follow up with preferred investments. But that’s not what we’re in the business of doing. Any university that counts on its tech transfer to make a significant change in its finances is statistically going to be in trouble.

About accelerators:

“Does MIT have an incubator?” And my classic answer has been, “Yes, it’s called the city of Cambridge.”

The problem with accelerators is the definition has become as broad and varied as incubators, which range from science parks to little projects within universities, so you don’t know what the word means until you dig in. But some of them are putting money into product development. Some of them are venture funds expecting ROI. Some of them are [funded] through donations, as we did with Deshpande and Harvard did with their accelerator.
It’s going to be interesting to look at the mechanisms that people are trying. Because the problem is there: How do we get from the stage of which the university has done its research and maybe even gotten on the cover of Science magazine, to where somebody is going to invest in that ripening process before it actually turns into true product development, short-term product development? How do you get from the petri dish to full-scale clinical trials? You’ve got to get pretty far along before pharma’s going to do that for you. So people are looking both within universities and outside of universities as to how you fill the gap.

About teaching entrepreneurship:

now MIT, with its emphasis on innovation, is investing officially in training students in innovation and entrepreneurship, along with, not separate from, their intense technical educations. It’s not “you go and learn how to be an entrepreneur,” it’s you learn biology or chemistry or electrical engineering or computer science, but you also learn how entrepreneurship and innovation and moving technology out into the marketplace works—rather than having to learn that after you graduate.

The Tinkerings of Robert Noyce – again

I read again The Tinkerings of Robert Noyce for reasons which are not directly related to Silicon Valley or Start-ups. A few days ago, I blogged about an extremely good article from the New Yorker – Our Town by Larissa MacFarquhar. The author illustrates some universal values of humankind through a small community in Iowa. And this reminded me of Tom Wolfe article written for Esquire Magazine in 1983. I found it again online here. It begins with : “In 1948 there were seven thousand people in Grinnell, Iowa, including more than one who didn’t dare take a drink in his own house without pulling the shades down first.” Robert Noyce studied at Grinnell College then left to MIT then to what would become Silicon Valley. Grinnell College was quite advanced in electronics. Tom Wolfe claims: “But MIT had proved to be a backwater… when it came to the most advanced form of engineering, solid-state electronics. Grinnell College, with its one thousand students, had been years ahead of MIT.” And later Grinnell College would invest in Intel, making its endowment unusually successful.

I was about to blog here about Wolfe’s article and (re)discovered, shame on me, that I had blogged about it in 2012! I had mentioneed the piece about the Wagon Wheel bar. Here it is again.

Or else he would leave the plant and decide, well, maybe he would drop in at the Wagon Wheel for a drink before he went home. Every year there was some place, the Wagon Wheel, Chez Yvonne, Rickey’s, the Roundhouse, where members of this esoteric fraternity, the young men and women of the semiconductor industry, would head after work to have a drink and gossip and brag and trade war stories about phase jitters, phantom circuits, bubble memories, pulse trains, bounceless contacts, burst modes, leapfrog tests, p-n junctions, sleeping-sickness modes, slow-death episodes, RAMs, NAKs, MOSes, PCMs, PROMs, PROM blowers, PROM burners, PROM blasters, and teramagnitudes, meaning multiples of a million millions. So then he wouldn’t get home until nine, and the baby was asleep, and dinner was cold, and the wife was frosted off, and he would stand there and cup his hands as if making an imaginary snowball and try to explain to her… while his mind trailed off to other matters, LSIs, VLSIs, alpha flux, de-rezzing, forward biases, parasitic signals, and that terasexy little cookie from Signetics he had met at the Wagon Wheel, who understood such things.

Here is another piece about stock options, which I discussed in another recent post: Rewarding Talent – A guide to stock options for European entrepreneurs by Index Ventures.

From the beginning Noyce gave all the engineers and most of the office workers stock options. He had learned at Fairchild that in a business so dependent upon research, stock options were a more powerful incentive than profit sharing. People sharing profits naturally wanted to concentrate on products that were already profitable rather than plunge into avant-garde research that would not pay off in the short run even if it were successful. But people with stock options lived for research breakthroughs. The news would send a semiconductor company’s stock up immediately, regardless of profits.

There would be so much more to say about this marvelous piece of Silicon Valley and American history. You should read it!

The complexity of innovation policies – the example of Malaysia

I was lucky to meet last week two economists from the International Monetary Fund who are the authors of the working paper The Leap of the Tiger: How Malaysia Can Escape the Middle-Income Trap. It is not directly linked to high-tech innovation and I am not an economist; my expertise is limied to the nano-economics of start-ups. This being said, I was very impressed by the analysis of Reda Cherif and Fuad Hasanov.

In general, I read more about developed countries and high-tech entrepreneurship, Silicon Valley, obviously, but also the example of Israel, Finland, France, Chile… Lerner, Saxenian and Mazzucato have been important authors for me. Hasanov and Cherif explain how Malaysia tried to develop its economy and relatively failed compared to Taiwan and Korea. The reasons are complex and the interested person should read their paper.

They really show the complexity of things and again the recipe needs so much fine tuning, with no guarantee of success. The addition of Chile, Thailand and Norway in their analysis, makes it really rich. I understood that a combination of strong state support (incentives, funding, sometimes protection) and competition in the private sector (so many Korean automotive firms were initially created) with an emphasis on its ability to export is very striking. Why did Nokia succeeded for some time and not Alcatel maybe explained with their arguments. They also put a lot of emphasis in the ability to innovate, a must to enable exportations.

So Mazzucato is right, the state has an entrepreneurial role, but individual initiatives seem to be also important, something I had not necessarily understood in the cased of Taiwan and Korea. The diaspora of engineers who studied and work abroad (in the USA mostly) was instrumental to the economic development and innovation once they came back (sometimes many years later) in their home country…